EJC Skin Cancer
Издатель: Elsevier · ISSN 2772-6118 · 85 статей
- Outcomes and prognostic factors of immune checkpoint inhibitor resumption in advanced melanoma, results from the MIRROR (melanoma immunotherapy resumption: Retrospective outcomes review) multicenter real-world study
- The survivorship experience of people with stage II-IV melanoma receiving adjuvant therapy: A real-world, prospective, longitudinal study
- Ten-year outcomes after initial response to immune checkpoint inhibitors in patients with advanced Merkel cell carcinoma
- Influence of dosage and therapeutic interval on the incidence of severe side effects of immunotherapy with PD-1 inhibitors in malignant melanoma
- Modality-specific prognostic and predictive factors in metastatic uveal melanoma
- Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma
- Tirbanibulin 1 % ointment: A narrative review of new data presented at the 11th World Congress of Melanoma in conjunction with 21st European Association of Dermato-Oncology Congress 2025
- Rapid reduction of immune checkpoint inhibitor–associated pruritus with nemolizumab
- Immune-related GFAP-Astrocytopathy under PD-1 inhibition: A case report
- Unusual site of superficial spreading melanoma in a young female with familial breast cancer
- Complete response with combined sonidegib and pembrolizumab in synchronous advanced basal cell carcinoma and metastatic cutaneous squamous cell carcinoma: A case report
- Rethinking locoregional therapy of Merkel cell carcinoma in the era of immune checkpoint inhibition
- Metastatic melanoma involving the uterine corpus: Diverse patterns of involvement and diagnostic pitfalls in a three-case series
- Mutational landscape in cutaneous melanoma
- Immunohistochemical predictors of sentinel lymph node metastasis in primary cutaneous melanoma: a systematic review and narrative synthesis
- An incomplete snapshot of the European melanoma clinical practice guidelines
- Why a 4 mm punch is not twice a 2 mm punch: The quadratic geometry of cutaneous surgical defects in skin cancer surgery
- Reponse to letter Re: Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study
- Letter Re: Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study
- Letter Re: Cryotherapy for actinic keratoses: A cross-sectional survey of real-world clinical practice
- Reply to letter Re: Long-term outcomes of cutaneous basal cell and squamous cell carcinomas with < 1 mm close primary surgical excision margins managed in a UK tertiary centre multidisciplinary team
- Letter Re: Long-term outcomes of cutaneous basal cell and squamous cell carcinomas with <1 mm close primary surgical excision margins managed in a UK tertiary centre multidisciplinary team
- Reply to: Letter regarding “Cryotherapy for actinic keratoses: A cross-sectional survey of real-world clinical practice”
- Squamoid eccrine ductal carcinoma of the head and neck: Three consecutive cases highlighting aggressive behavior and diagnostic pitfalls
- Metastatic Spiradenocarcinoma Successfully Treated With Combined Ipilimumab and Nivolumab